David Pendarvis - Nov 18, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administration Officer
Signature
David Pendarvis, Chief Administration Officer
Stock symbol
RMD
Transactions as of
Nov 18, 2021
Transactions value $
$0
Form type
4
Date filed
11/22/2021, 07:00 PM
Previous filing
Nov 18, 2021
Next filing
Dec 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RMD ResMed Common Stock 119K Nov 18, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Award $0 +5.93K $0.00 5.93K Nov 18, 2021 ResMed Common Stock 5.93K $263.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2022, 2023 and 2024.